Bulis Veronica Sanchez

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 21% 8.2% 15.1%
Success rate 90% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Bulis Veronica Sanchez's trades of Lyell Immunopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
32.32
Quantity 936 -11.6%
Value US$30,252
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-11 2026-08-10
S Sale
27,523 -7.9%
67.88
US$1,427,440 		27,523 -7.9% 67.88 US$1,427,440
2026-06-15 2026-05-11
S Sale
93,410 +38.1%
76.80
US$4,523,703 		93,410 +38.1% 76.80 US$4,523,703
2026-02-11 2026-02-10
S Sale
79,227 +26.7%
107.89
US$335,367 		79,227 +26.7% 107.89 US$335,367
2026-01-06 2025-12-30
S Sale
936 -11.6%
32.32
US$30,252 		936 -11.6% 32.32 US$30,252
2026-01-06 2025-12-24
S Sale
1,136 -12.3%
38.67
US$43,929 		1,136 -12.3% 38.67 US$43,929
2025-11-12 2025-11-10
S Sale
239 -2.5%
16.10
US$3,848 		239 -2.5% 16.10 US$3,848